Suvirux™ is indicated for the treatment of genotype 1, 2, 3 or 4 chronic hepatitis C virus (HCV) infection as a component of a combination antiviral treatment regimen.
Dosage & Administration:
One tablet once daily with or without food. It should be used in combination with Ribavirin or in combination with Peg-Interferon and Ribavirin for the treatment of HCV.
Suvirux™ Tablet: Each box contains 12 Tablets in a blister pack.